Not Yet Recruiting
Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial
NCT07722754
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +14 more
- Locations
-
Not specified